Covered recipient · General Payments record
MATTHEW THOMAS MANZO
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$3,454.18
- Reported across 207 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $203.61 | 12 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $52.37 | 3 |
| Lilly USA, LLC | $31.14 | 2 |
| Corcept Therapeutics | $30.29 | 2 |
| ABBVIE INC. | $25.32 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $18.53 | 1 |
| Acerta Pharma LLC | $16.76 | 1 |
| Xeris Pharmaceuticals, Inc. | $15.08 | 1 |
| Amgen Inc. | $14.12 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $25.32 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104961876 | CMS |
| Amgen Inc. | $14.12 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115901491 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.76 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104510600 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $18.53 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117985368 | CMS |
| Corcept Therapeutics | $13.73 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117791352 | CMS |
| Corcept Therapeutics | $16.56 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117791438 | CMS |
| Lilly USA, LLC | $16.10 | 04/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135195238 | CMS |
| Lilly USA, LLC | $15.04 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135200499 | CMS |
| Novo Nordisk Inc | $14.51 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096903027 | CMS |
| Novo Nordisk Inc | $22.20 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097691611 | CMS |
| Novo Nordisk Inc | $15.66 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097195444 | CMS |
| Xeris Pharmaceuticals, Inc. | $15.08 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144605128 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.